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Abstract
The infiltration of T-lymphocytes in the stroma and tumour is an indication of an effective immune response against
the tumour, resulting in better survival. In this study, our aim was to explore the prognostic significance of tumour-
associated stroma infiltrating lymphocytes (TASILs) in head and neck squamous cell carcinoma (HNSCC) through an
AI-based automated method. A deep learning-based automated method was employed to segment tumour, tumour-
associated stroma, and lymphocytes in digitally scanned whole slide images of HNSCC tissue slides. The spatial pat-
terns of lymphocytes and tumour-associated stroma were digitally quantified to compute the tumour-associated
stroma infiltrating lymphocytes score (TASIL-score). Finally, the prognostic significance of the TASIL-score for
disease-specific and disease-free survival was investigated using the Cox proportional hazard analysis. Three differ-
ent cohorts of haematoxylin and eosin (H&E)-stained tissue slides of HNSCC cases (n = 537 in total) were studied,
including publicly available TCGA head and neck cancer cases. The TASIL-score carries prognostic significance
(p = 0.002) for disease-specific survival of HNSCC patients. The TASIL-score also shows a better separation between
low- and high-risk patients compared with the manual tumour-infiltrating lymphocytes (TILs) scoring by patholo-
gists for both disease-specific and disease-free survival. A positive correlation of TASIL-score with molecular esti-
mates of CD8+ T cells was also found, which is in line with existing findings. To the best of our knowledge, this is
the first study to automate the quantification of TASILs from routine H&E slides of head and neck cancer. Our
TASIL-score-based findings are aligned with the clinical knowledge, with the added advantages of objectivity, repro-
ducibility, and strong prognostic value. Although we validated our method on three different cohorts (n = 537 cases
in total), a comprehensive evaluation on large multicentric cohorts is required before the proposed digital score can
be adopted in clinical practice.
© 2021 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great
Britain and Ireland.
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Introduction
There are around 900 000 annual new cases of head and
neck cancers worldwide and 450 000 annual deaths [1].
Head and neck squamous cell carcinoma (HNSCC)
accounts for approximately 90% of head and neck
cancers and is the sixth leading cancer by incidence
worldwide [2]. HNSCC predominantly develops in the
epithelial lining of the oral cavity, sinonasal tract,
pharynx, and larynx [3]. Major risk factors include
tobacco smoking, tobacco chewing, alcohol consump-
tion, and human papillomavirus infection [4,5]. The
prognosis of HNSCC remains poor, with a 28–67%
chance of survival at 5 years [6], highlighting the need
for novel biomarkers and objective quantitative analysis
of any potential prognostic markers to stratify patients
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into appropriate risk groups and identify those who may
benefit from aggressive treatment from those that can be
put under surveillance [7].
Tumour-infiltrating lymphocytes (TILs) have been
shown to be of prognostic significance for HNSCC
[8,9]. TILs are not routinely quantified in diagnostic
practice, although somemethods for manual TIL scoring
on haematoxylin and eosin (H&E)-stained tissue sec-
tions have been reported in the literature. However, this
quantification process is subjective and prone to inter-
and intra-observer variability. Recently, the Interna-
tional Immuno-Oncology Biomarker Working Group
has developed guidelines for TIL assessment in breast
cancer [10] to standardise and obtain a more reproduc-
ible and objective TIL score. However, there are no such
guidelines for TIL assessment in HNSCC. Therefore, a
computer-based automated method may help to elimi-
nate the subjectivity through objective TIL quantifica-
tion and assist with prognostic stratification.
The emerging area of computational pathology has
seen a surge of interest in recent years, with a variety
of algorithms proposed in the literature for detection of
lymph node metastasis in breast cancer [11], tumour
detection [12] and segmentation [13–15], cancer grading
[16,17], and prognostics [18–20], to list only a few.
There have been some studies on automated quantifica-
tion of lymphocytic infiltration in whole slide images
(WSIs) of H&E-stained histology tissue slides of differ-
ent cancers. For instance, Saltz et al [21] quantified the
spatial patterns of lymphocytes in WSIs, independent
of tumour location, to investigate their prognostic signif-
icance in 14 different cancer types. Maley et al [22]
reported co-localisation between immune cells and can-
cer cells as a prognostic factor for breast cancer. Nawaz
et al [23] used hotspot analysis to identify the statisti-
cally significant regions of cancer and immune cells.
Shaban et al [19] quantified the abundance of TILs for
disease-free survival (DFS) analysis of oral squamous
cell carcinoma (OSCC) patients. Most existing auto-
mated quantification methods either only consider lym-
phocytes or lymphocytic infiltration in tumour regions.
However, some clinical studies [24,25] have reported
the prognostic significance of lymphocyte infiltration in
tumour-associated stroma (TAS) in HNSCC.
We propose a novel objective quantification method
of lymphocytic infiltration in TAS (see Figure 1). The
proposed method calculates the percentage of TAS co-
localised with lymphocytes, which we term the TASIL-
score. We evaluate the prognostic significance on three
independent patient cohorts (n = 537 cases in total).
The proposed TASIL-score shows prognostic signifi-
cance (p = 0.002) for disease-specific survival (DSS)
of HNSCC patients. The TASIL-score is also a prognos-
tic indicator for DSS and DFS in two OSCC and oropha-
ryngeal squamous cell carcinoma (OPSCC) cohorts. We
have also compared the predictive ability of a TASIL-
score-based survival model with existing quantification
methods through a concordance index measure where
the TASIL-score achieved the highest concordance com-
pared with its counterparts.
Materials and methods
Clinical samples
Three different patient cohorts (TCGA-HN [26], SKM
[19], and PredicTR1 [27]) were used in this study. The
TCGA-HN cohort (C1) is a publicly available dataset
which comprises 450 diagnostic H&E WSIs of squa-
mous cell carcinoma (SCC) cases from different sites
of the head and neck (H&N). However, many of these
slides suffer from preparation and scanning artefacts.
After excluding cases with slides of poor quality, our
final TCGA-HN cohort consisted of 342 cases with one
WSI per case (see supplementary material, Tables S6).
The H&E WSIs from these cases had mostly been
scanned at 40, with some scanned at 20. The SKM
cohort (C2) consists of 100 OSCC cases collected from
the Shaukat Khanum Memorial Hospital and Research
Centre (SKMCH&RC) Lahore, Pakistan [19]. The Pre-
dicTR1 cohort (C3) contains 95 OPSCC cases collected
from six different centres across the UK [27]. The repre-
sentative H&E tissue sections for both the SKM and
the PredicTR1 cohort were all scanned at 40
magnification.
Ethics statement
Ethical approval for SKM [19] was obtained from the insti-
tutional review board (Ref. No. 17-02-17-10) at
SKMCH&RC and the National Bioethics Committee
(No. 4-87/17/NBC-234-Exempt/NBC/2592), Pakistan.
Cases for the PredicTR1 cohort [27] were collected from
six different centres after receiving approval fromResearch
Ethics Committee (REC 11/NQ/0452) and Northern Ire-
land Biobank (NIB 11/001).
Survival information
DSS information was available and was obtained for
most of the selected cases in all three cohorts. The
DSS time was calculated from the date of diagnosis
to the date of death or the date of the last follow-up
in the case of censored data. DFS information was
only available for the C2 and C3 cohorts. The DFS
was censored at the date of first recurrence or death,
whichever occurred first, or the date of the last contact
for patients alive without recurrent disease. A detailed
description of the patients’ characteristics and avail-
able clinical and pathological parameters can be found
in Supplementary materials and methods and supple-
mentary material, Tables S1–S3.
Quantification of tumour-associated stroma
infiltrating lymphocytes
We have developed an objective and automated score for
the quantification of tumour-associated stroma infiltrat-
ing lymphocytes, namely the TASIL-score, which quan-
tifies lymphocytes in the vicinity of TAS using the
spatial co-occurrence statistics of both TAS and lympho-
cytes in a WSI. The TASIL-score is computed in two
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steps: segmentation of WSIs into clinically significant
tissue types and calculation of the spatial co-occurrence
statistics.
In the first step, we divided a given WSI into small
sub-images (patches) and employed a deep learning-
based patch classification method to segment the
WSI into four different types of regions: tumour,
TAS, lymphocytes, and all other tissue regions as
non-regions of interest (non-ROIs). In the second
step, spatial co-occurrence statistics were calculated
using the co-occurrence analysis of different types
of patches in a WSI. A patch adjacent to another patch
in any direction was considered as an instance of co-
occurrence. First, six different patch co-occurrence
patterns were defined based on three clinically signif-
icant tissue types, as shown in supplementary
Figure 1. Flow diagram of the proposed method. (A) A whole slide image (WSI) (H&E-stained). (B) Image patches extracted from theWSI. (C) A
convolutional neural network-based patch segmentation method. (D) Patch-based segmentation results, where red, green, blue, and black
colours represent tumour, lymphocyte, tumour-associated stroma, and non-regions of interest, respectively. (E) Segmentation map of the
WSI. (F) Overlay of the segmentation map over the WSI. (G) Analysis of the spatial co-occurrence of tumour, lymphocyte, and tumour-
associated stroma regions. (H) Calculation of the proposed TASIL-score based on the number of each pair of co-occurrences. (I) TASIL-
score-based patient stratification into low- and high-risk groups.
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where SL represents the number of times tumour-
associated stroma and lymphocyte patches co-occur in
a WSI. Similarly, SS and ST denote the number of
co-occurrences of TAS patches with other TAS
patches and tumour patches, respectively. The
TASIL-score ranges from 0 to 1, where 0 represents
no infiltration and 1 represents a high degree of
lymphocytic infiltration in the tumour-associated
stroma.
Statistical methods and data analysis
Survival analysis was performed with DSS and DFS data.
The Kaplan–Meier estimator was used, and the log-rank
test was performed to stratify patients into low- and high-
risk groups (log-rank test-based P values were calculated
to assess the significance of the various features including
the proposed TASIL-score). The Cox proportional hazard
regression model was used for univariate and multivariate
analyses and 95% confidence intervals were computed.
The Spearman rank-order correlation coefficient was used
for correlation analyses between TASIL-score andmolecu-
lar estimates, and between TASIL-score and the manual
TIL score assigned by a pathologist. The concordance sta-
tistics were used to compare the different automated quan-
tification scores for DSS analysis.
Supplementary materials and methods presents
detailed descriptions of patients’ characteristics,
data annotations, and the artificial intelligence
(AI) method.
Results
Automated segmentation of whole slide images for
quantification of the TASIL-score
A deep learning-based segmentation algorithm was
trained and evaluated on WSIs from the C1 and C2
cohorts, where ten WSIs were used for training and
two for validation from each cohort. More than 179K
patches (141K for training and 38K for validation) were
annotated by an expert pathologist (SAK). The segmen-
tation method achieved an average accuracy of 0.85 and
macro F1-score of 0.83. Quantitative and visual results
for WSI segmentation are presented in supplementary
material, Table S5 and Figure S2. Performance of the
segmentation method was further evaluated by calculating
the Spearman correlation between the percentage of pre-
dicted lymphocyte patches (L-Percentage) and the pathol-
ogists’ manually assigned TIL score on the C3 cohort.
The pathologists scored TILs on an H&E slide under
2.5 magnification as high (diffuse, lymphocytes present
in more than 80% of tumour/tumour-associated stroma),
low (weak/absent, lymphocytes present in less than
20% of tumour/tumour-associated stroma), or moderate
(patchy, present in 20–80% tumour/tumour-associated
stroma) [28]. A Spearman correlation score of 0.71 with
a highly significant P value of 5.10 1016 was observed
between the two scores. The distribution of L-Percentage
across the three groups of the pathologists’ TIL score
showed a clear separation (see supplementary material,
Figure S3).
Higher TASIL-score is associated with better
disease-specific survival of HNSCC patients
We investigated the prognostic significance of the
deep learning-based TASIL-score for DSS of HNSCC
Figure 2. Kaplan–Meier curves for low- and high-risk patients in (A) the C2 and C3 cohorts and (B) the C1 cohort when used as validation
cohorts for disease-specific survival (DSS).
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patients. First, we considered C1 as a discovery cohort
and both C2 and C3 as a joint validation cohort. Patients
in the validation cohort were divided into two groups
based on the TASIL-score using an optimal threshold
value obtained from the analysis of the discovery cohort.
We found that the patient group with the higher TASIL-
score showed a significantly better DSS [p = 0.000003,
hazard ratio (HR) = 0.20, 95% confidence interval (CI)
0.10–0.43] on the validation cohort. The TASIL-score
was again statistically significant for patient stratification
for DSS (p = 0.00239, HR = 0.49, 95% CI 0.30–0.78)
when the discovery and validation cohorts were
swapped. The Kaplan–Meier curves along with the cor-
responding log-rank test-based P values are presented in
Figure 2. These curves show a clear separation between
low- and high-risk patient groups when stratified using
the TASIL-score.
TASIL-score is a prognostic indicator for the SCC of
both oral and oropharynx sites
The C2 and C3 cohorts were curated from only the oral
cavity and oropharynx, respectively. Therefore, we
investigated the prognostic significance of TASIL-score
for patients with SCC of a specific site. First, the OSCC
cohort (C2) was considered as a discovery cohort and the
OPSCC cohort (C3) was considered as a validation
cohort. Supporting our aforementioned findings, the
TASIL-score remained prognostically significant
(p = 0.000159, HR = 0.20, 95% CI 0.08–0.49) for
Figure 3. Kaplan–Meier curves for low- and high-risk patients in the oropharyngeal (A, C) and oral (B, D) cohorts when used as validation
cohorts for disease-specific (A, B) and disease-free (C, D) survival.
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Table 1. Multivariate analysis of TASIL-score in the presence of available clinical and pathological variables of the SKM cohort for both
disease-specific and disease-free survival.
Disease-specific survival Disease-free survival
95% CI 95% CI
Variable HR Lower Upper P value HR Lower Upper P value
Age 1.015 0.969 1.060 0.526 1.010 0.980 1.040 0.579
Sex 2.057 0.502 8.430 0.316 1.540 0.650 3.660 0.323
Smoking tobacco 1.905 0.505 7.190 0.342 1.160 0.510 2.690 0.72
Smokeless tobacco 0.671 0.156 2.900 0.593 1.990 0.770 5.130 0.155
Tumour grade 0.689 0.312 1.520 0.355 1.090 0.660 1.790 0.73
Invasion pattern 1.121 0.653 1.920 0.678 1.350 0.930 1.950 0.115
TNM stage 2.015 1.021 3.970 0.043 1.090 0.780 1.520 0.627
TASIL 0.099 0.013 0.760 0.027 0.290 0.120 0.670 0.004
Values in bold indicate statistically significant differences.
Figure 4. Multivariate analysis of TASIL-score in the presence of available clinical and pathological variables of the C1 cohort. Dotted lines
represent hazard ratios.
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OPSCC patient stratification into low- and high-risk
groups for DSS. Second, we swapped the two cohorts,
considering the OPSCC cohort (C3) as the discovery
cohort and the OSCC cohort (C2) as the validation
cohort. We found that the TASIL-score-based OSCC
patient stratification again proved prognostically signifi-
cant (p = 0.000935, HR = 0.08, 95% CI 0.01–0.65).
When the experiments were repeated to evaluate the
prognostic significance of the TASIL-score for DFS,
the same pattern, where the TASIL-score stratified
patients into prognostically significant low- and high-
risk groups, was followed. Patient stratification into
low- and high-risk groups is presented in Figure 3
through Kaplan–Meier curves for all four experiments.
Figure 5. Comparison of the manual pathologist TIL score (A, B – Low &Moderate versus High; C, D –Low versus Moderate& High) and the
proposed TASIL-score (E, F) in a univariate setting for disease-specific (A, C, E) and disease-free survival (B, D, F) of the C3 cohort.
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TASIL-score is independent of clinical and
pathological variables
We investigated the prognostic significance of the
TASIL-score through multivariate analysis in the pres-
ence of clinical and pathological variables. The C2
cohort was considered for multivariate analysis as it
has more clinical and pathological parameters, along
with both DSS and DFS information (supplementary
material, Table S2), compared with the other two
cohorts. For DSS, both TASIL-score (p = 0.027,
HR = 0.10, 95% CI 0.01–0.76) and pathological stage
(p = 0.043, HR = 2.02, 95% CI 1.02–3.97) were found
to be independent prognostic variables against all other
variables (Table 1). However, for DFS, TASIL-score
was the only independent variable of statistical signifi-
cance (p = 0.004, HR = 0.29, 95% CI 0.12–0.67)
against age, sex, smoke and smokeless tobacco status,
tumour grade, patterns of invasion, and pathological
stage. We also investigated the prognostic significance
of TASIL-score for DSS in a multivariate setting on
the C1 cohort using the available clinical and pathologi-
cal variables. The TASIL-score remained prognostic
(p = 0.043, HR = 0.58, 95% CI 0.34–0.98) in the pres-
ence of other clinicopathological variables: age, gender,
grade, and pathological stage. Although stages IVb and
IVc appeared to be statistically significant, the total num-
ber of patients in stages IVb and IVCwas 9 and 1, respec-
tively, which is quite small compared with the total
number of patients (Figure 4).
TASIL-score shows a better separation between low-
and high-risk patients compared with the manual TIL
score
The pathologist score for tumour/stroma infiltrating
lymphocytes is usually a categorical score with low,
moderate, and high infiltration categories. Only low
and high categories showed prognostic significance
in the C3 cohort for DSS and DFS, as shown in sup-
plementary material, Table S3. We merged the mod-
erate category in two different ways to split the
patients into low- and high-risk groups (see
Figure 5). The Kaplan–Meier curves in Figure 5
show that the TASIL-score stratifies patients into
low- and high-risk groups with better prognostic sig-
nificance compared with the manual TIL score in
both DSS and DFS analyses.
Figure 6. Spearman correlation between TASIL-score and molecular estimates of (A) macrophage and (B) T-cell fractions.
Table 2. Concordance index of different tumour, tumour-associated stroma, and lymphocyte quantification methods, including the proposed
TASIL-score.
Survival type Cohort TS-Ratio IC-co-localization TILAb TASIL
Disease-specific survival C1 0.4833 0.6180 0.6062 0.6146
Disease-specific survival C2 0.5931 0.6028 0.6219 0.6992
Disease-specific survival C3 0.5965 0.6228 0.5926 0.6943
Disease-specific survival C2 and C3 0.5884 0.6701 0.6587 0.7248
Disease-free survival C2 0.5591 0.6589 0.6815 0.6546
Disease-free survival C3 0.6274 0.7113 0.7075 0.7698
Bold values indicate the highest concordance-index score in each row.
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Comparison with existing digital scores
In recent years, researchers have proposed several auto-
mated quantification methods for co-localisation in
different types of cancers to develop a digital prognos-
tic biomarker [19,22,29,30]. The use of computerised
methods addresses the issue of subjectivity and pro-
duces objective and reproducible quantification scores.
Geessink et al [30] presented tumour to stroma ratio
(TS-Ratio) for rectal adenocarcinoma and showed that a
higher TS-Ratio had prognostic association with poor
patient survival. Maley et al [22] used an ecological mea-
sure for quantification of co-localisation between immune
cells and cancer cells (IC-Co-localisation) in breast can-
cer. They found that higher co-localisation of immune
and tumour cells was associated with better patient
survival.
Similarly, Shaban et al [19] proposed a tumour-
infiltrating lymphocytes abundance (TILAb) score for
OSCC which showed prognostic significance for DFS
in both univariate and multivariate analysis. We used
Harrell’s concordance index (C-Index) to compare the
predictive ability of the TASIL-score with the existing
automated quantification methods in six different exper-
iments. Table 2 presents C-Index scores on all cohorts
when used as validation. The proposed TASIL-score
achieved the best C-Index scores in four experiments
and comparable C-Index scores in the remaining two
experiments for DSS and DFS.
TASIL-score is correlated with molecular estimates of
CD8+ T cells
We further investigated the correlation of the proposed
TASIL-score with molecular estimates of immune cell
fractions in the TCGA-HN cohort (C1). Thorsson et al
[31] have estimated the fraction of 22 immune cell types
in the histology slides of patients in the TCGA cohort
using gene expression data through CIBERSORT. We
used those estimates for the correlation analysis with
our TASIL-score. The immune subtypes were grouped
based on nine different immune cell types: dendritic,
mast, neutrophils, eosinophils, monocytes, macro-
phages, natural killer cells, T cells, and B cells. Our main
finding was that the TASIL-score shows a moderate but
highly significant positive correlation with T-cell esti-
mates and a negative correlation with macrophage esti-
mates (Figure 6).
Moreover, CD8+ T-cell fraction shows the highest
positive correlation among all immune subtypes
(Table 3), which may indicate that the lymphocytes in
the vicinity of the TAS are mainly CD8+ T cells [32].
An explanation for the value of the correlation between
TASIL-score and cell fractions not being very high is that
TASIL-score and the molecular estimates are computed
on formalin-fixed, paraffin-embedded (FFPE) and fresh
frozen tissue sections, respectively. Both tissue sections
belong to tissue blocks from the same patient, but their
exact spatial relation is unknown. However, a good cor-
relation of TASIL-score with CD8+ T cells indirectly
validates the significance of the proposed score.
Discussion
We have proposed a deep learning-based objective mea-
sure, namely the TASIL-score, for quantification of
tumour-associated stroma infiltrating lymphocytes in
digitised images of HNSCC tissue slides. We found that
a higher value of the TASIL-score was associated with
better DSS of HNSCC patients (Figure 2) and with both
DSS and DFS of OSCC and OPSCC patients (Figure 3).
The TASIL-score was independent of clinicopathologi-
cal parameters for DSS and DFS of OSCC patients
(Table 1). It also showed a better separation between
low- and high-risk OPSCC patients compared with the
manual TIL score assessed by an expert pathologist
(Figure 5). We compared the TASIL-score with the
existing automated quantification methods for stroma
Table 3. Spearman correlation between TASIL-score and molecular estimates of immune subtypes.
Cell type rho P value Cell subtypes rho P value
Mast cells 0.18 8.22  104 Activated 0.18 1.19  103
Resting 0.12 2.84  102
Monocytes 0.18 7.70  104 Monocytes 0.18 7.70  104
Macrophages 0.37 2.67  1012 M0 0.39 2.08  1013
M1 0.32 2.62  109
M2 0.24 1.05  105
T cells 0.46 1.32  1018 CD4 memory activated 0.32 2.04  109
CD4 memory resting 0.09 9.66  102
CD4 naive 0.20 3.11  104
CD8 0.45 9.28  1018
Follicular helper 0.26 2.37  106
Gamma-delta 0.07 1.94  101
Regulatory 0.26 1.16  106
B cells 0.22 3.97  105 Memory 0.02 7.37  101
Naive 0.22 4.32  105
Plasma 0.11 4.77  102
Values in bold indicate statistically significant differences.
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and lymphocytic quantification with respect to the
tumour. The TASIL-score achieved a high concordance
score compared with its counterparts (Table 2) and also
showed a moderate but highly significant correlation
with molecular estimates of CD8+ T cells (Table 3).
Most of the existing automated quantification methods
were developed for the quantification of lymphocytes or
stroma in relation to the tumour, such as stroma to tumour
ratio in breast and ovarian cancer [29,30], lymphocyte and
tumour co-localisation in breast cancer [22], and abundance
of tumour-infiltrating lymphocytes in OSCC [19]. How-
ever, automated quantification of stromal TILs has not been
fully explored yet. To the best of our knowledge, the pro-
posed TASIL-score is the first automated quantitative score
of lymphocytic infiltration in the TAS of HNSCC.
The role of TASIL has been investigated in several
clinical studies of different cancers [10,24,25]. Salgado
et al [10] found that stromal TILs are a superior andmore
reproducible prognostic parameter than intratumoral
TILs in breast cancer. Xu et al [25] also reported that
stromal TILs were of clinical relevance as a high stromal
TIL score was associated with better patient prognosis
for HNSCC. Furthermore, stromal TILs have been
shown to be an independent risk factor for DSS and
DFS of HNSCC patients. Our automated TASIL-score
shows a similar prognostic significance pattern (see
Figures 2 and 3).
In clinical practice, both H&E staining and immuno-
histochemistry (IHC) staining are used for manual TIL
scoring. The TASIL-score-based results are in agree-
ment with previous findings based on H&E- and IHC-
based TIL quantification [24,33,34]. In Figure 5, we
have shown that both the manual H&E-based patholo-
gist score and the TASIL-score carry prognostic signifi-
cance for DSS and DFS of OPSCC. However, the
TASIL-score shows better separation between Kaplan–
Meier curves of low- and high-risk patients of OPSCC.
We also visually analysed two cases with low and
high TASIL-score from the group of TIL-High and
TIL-Low cases, respectively (supplementary material,
Figures S5 and S6). Visual analysis of supplementary
material, Figure S5 reveals that the difference between
the TASIL score and the pathologist’s manual TIL score
is largely due to the difference in their definitions. The
proposed digital TASIL-score quantifies lymphocyte
infiltration in tumour-associated stroma (TAS), whereas
the manual TIL score attempts to quantify lymphocyte
infiltration in both tumour and TAS, where applicable.
de Ruiter et al [33] conducted a meta-analysis of IHC-
based studies to investigate the prognostic value of
T cells in HNSCC. They found a favourable prognostic
role of CD3+ and CD8+ T-cell infiltration in HNSCC
patients. Balermpas et al [24] found that high CD8
expression in tumour stroma is a prognosticator for
HNSCC. The proposed TASIL-score also shows a posi-
tive and highly significant correlation with genomic esti-
mates of CD8+ T cells in HNSCC patients in the TCGA-
HNSCC cohort.
One of the limitations of this work is the marked dif-
ference in low- and high-risk groups across different
cohorts. The separation between low- and high-risk
groups in the C2 and C3 cohorts is more sustained com-
pared with the C1 cohort. The slight difference in perfor-
mance on C1 may be attributed to stain variation and
scanner differences, known as the domain shift problem
in the area of computational pathology [35–37]. While
we have shown the TASIL-score to be prognostically
significant across all three cohorts (including C1), the
score must be evaluated for robustness to stain variation
and scanner differences before it can be deployed in
clinical practice. Moreover, image quality in C1 is low
compared with C2 and C3, which may result in poor
segmentation of tumour, tumour-associated stroma,
and lymphocytic regions (see supplementary material,
Figures S7–S9). Another limitation of this work is
the moderate correlation between the TASIL-score and
molecular estimates of CD8+ T cells. Further investiga-
tion is required to improve the correlation by including
other co-occurrence patterns in the TASIL-score,
e.g. lymphocyte to lymphocyte co-occurrence. A higher
correlation between tailored TASIL-score and the CD8+
T cells will also justify the TASIL-score’s better survival
stratification than the manual TIL score. However, the
investigation of tailored TASIL-score with better corre-
lation with CD8+ T cells is beyond the scope of this
study and a good future direction.
T-lymphocyte infiltration in the stroma and tumour
indicates an effective immune challenge to the tumour
and is related to better outcome and treatment response.
The proposed TASIL-score-based findings are aligned
with the clinical knowledge, with the added advantages
of objectivity, reproducibility, and strong prognostic
value. Therefore, the automated, objective, and quantita-
tive TASIL-score has the potential to provide valuable
insights into tumour behaviour and prognosis in an effi-
cient and consistent manner. Although we validated our
method on three different cohorts (n = 537 cases in total),
a comprehensive evaluation on large multicentric cohorts
is required before the proposed digital score can be
adopted in clinical practice.
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Supplementary materials and methods
Figure S1. Visual illustration of patch co-occurrence analysis
Figure S2. The architecture of the segmentation network using DenseNet as a baseline
Figure S3. Boxplot representation of L-Percentage and pathologist’s manual TIL score for all cases in the C3 cohort
Figure S4. Visual results of our segmentation method
Figure S5. Predictions of tumour, tumour-associated stroma, and lymphocytic regions for a WSI with the lowest TASIL-score amongWSIs with a high
manual TIL score
Figure S6. Predictions of tumour, tumour-associated stroma, and lymphocytic regions for a WSI with the highest TASIL-score amongWSIs with a low
manual TIL score
Figure S7. An exemplar tissue region where the deep learning-based segmentation method did not perform well
Figure S8. Another exemplar tissue region where the deep learning-based segmentation method did not perform well
Figure S9. Whole slide images (WSIs) showing staining and tissue artefacts
Table S1. Summary of parameters available for the C1 cohort along with log-rank test-based P values for disease-specific survival (referred to in Sup-
plementary materials and methods)
Table S2. Summary of parameters available for the C2 cohort along with log-rank test-based P values for disease-specific survival (DSS) and disease-
free survival (DFS)
Table S3. Summary of parameters available for the C3 cohort along with log-rank test-based P values for disease-specific survival (DSS) and disease-
free survival (DFS)
Table S4. Distribution of annotated regions (sub-images or patches) for each class in both training and validation sets (referred to in Supplementary
materials and methods)
Table S5. Comparison of different patch-based WSI segmentation methods
Table S6. List of the 342 TCGA-HNSC cases used in this study
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